Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine 2% peribulbar block versus topical anesthesia for cognitive function in elective cataract surgery
PACTR201903779653918Phase 3Not yet recruiting
- Sponsor
- Beni-Suef University Hospital
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of lidocaine in cataract (2 arms), sponsored by Beni-Suef University Hospital. Primary endpoint: Cognitive function. Planned start May 2018; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
cataract
Beyond the preview
Go deeper on PACTR201903779653918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201903779653918.